10:30 AM EDT, 03/24/2026 (MT Newswires) -- Guardant Health ( GH ) said Tuesday it partnered with Verana Health, allowing researchers access to Verana's electronic health record datasets and Guardant's clinicogenomic testing data to boost the development of new therapies and improve patient care.

The partnership will allow researchers to understand and validate correlations between molecular biomarkers, treatment decisions and clinical outcomes using combined real-world data. The joint data set includes information across multiple cancer types such as lungs, breasts and colorectal tumors.

Price: 82.93, Change: -1.97, Percent Change: -2.32